Professional Documents
Culture Documents
ADVANCES IN
FOOD AND NUTRITION
RESEARCH
ADVISORY BOARDS
David Rodríguez-Lázaro
Loong-Tak Lim
Michael Eskin
Isabel Ferreira
Crispulo Gallegos
Se-Kwon Kim
Keizo Arihara
SERIES EDITORS
GEORGE F. STEWART (1948–1982)
EMIL M. MRAK (1948–1987)
C. O. CHICHESTER (1959–1988)
BERNARD S. SCHWEIGERT (1984–1988)
JOHN E. KINSELLA (1989–1993)
STEVE L. TAYLOR (1995–2011)
JEYAKUMAR HENRY (2011–2016)
FIDEL TOLDRÁ (2016– )
VOLUME EIGHTY NINE
ADVANCES IN
FOOD AND NUTRITION
RESEARCH
Edited by
FIDEL TOLDRÁ
Instituto de Agroquímica y Tecnología de Alimentos (CSIC),
Valencia, Spain
Academic Press is an imprint of Elsevier
50 Hampshire Street, 5th Floor, Cambridge, MA 02139, United States
525 B Street, Suite 1650, San Diego, CA 92101, United States
The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, United Kingdom
125 London Wall, London, EC2Y 5AS, United Kingdom
No part of this publication may be reproduced or transmitted in any form or by any means, electronic
or mechanical, including photocopying, recording, or any information storage and retrieval system,
without permission in writing from the publisher. Details on how to seek permission, further
information about the Publisher’s permissions policies and our arrangements with organizations such
as the Copyright Clearance Center and the Copyright Licensing Agency, can be found at our website:
www.elsevier.com/permissions.
This book and the individual contributions contained in it are protected under copyright by the
Publisher (other than as may be noted herein).
Notices
Knowledge and best practice in this field are constantly changing. As new research and experience
broaden our understanding, changes in research methods, professional practices, or medical
treatment may become necessary.
Practitioners and researchers must always rely on their own experience and knowledge in evaluating
and using any information, methods, compounds, or experiments described herein. In using such
information or methods they should be mindful of their own safety and the safety of others, including
parties for whom they have a professional responsibility.
To the fullest extent of the law, neither the Publisher nor the authors, contributors, or editors, assume
any liability for any injury and/or damage to persons or property as a matter of products liability,
negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas
contained in the material herein.
ISBN: 978-0-12-817171-4
ISSN: 1043-4526
Contributors ix
Preface xiii
1. Introduction 2
2. Determinants of beverage consumption 3
3. Genetic determinants of beverage consumption 4
4. Implications of genetic knowledge on beverage consumption 28
5. Conclusions 35
Acknowledgment 36
References 36
Further reading 52
v
vi Contents
3. Cheese 112
4. Butter 121
5. Ice cream 132
6. Dairy desserts 141
7. Conclusions 145
References 145
Further reading 164
1. Introduction 260
2. Aquaculture products nutritional composition 265
3. Insects nutritional composition 272
4. Extraction methods to recover proteins 278
5. Analysis of the extracts 279
6. Purification and fractionation stages 283
7. Development of new products based on insect proteins and aquaculture
products 284
8. Challenges and future perspectives of aquaculture products as protein
sources 286
9. Challenges and future perspectives of insects as proteins source 288
Acknowledgments 289
References 289
C.M. Alfaia
Centro de Investigação Interdisciplinar em Sanidade Animal (CIISA), Faculdade de Medicina
Veterinária, Universidade de Lisboa, Avenida da Universidade Tecnica, Pólo Universitário
do Alto da Ajuda, Lisbon, Portugal
K. Arihara
School of Veterinary Medicine, Kitasato University, Tokyo, Japan
Merve Bacanli
Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Hacettepe University,
Ankara, Turkey
Celso Fasura Balthazar
Universidade Federal Fluminense (UFF), Faculdade de Veterinária, Niterói, Brazil
Francisco J. Barba
Nutrition and Food Science Area, Preventive Medicine and Public Health, Food Science,
Toxicology and Forensic Medicine Department, Faculty of Pharmacy, Universitat de
València, València, Spain
A. Ahmet Başaran
Faculty of Pharmacy, Department of Pharmacognosy, Hacettepe University, Ankara, Turkey
Nurşen Başaran
Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Hacettepe University,
Ankara, Turkey
Danijela Bursac Kovacevic
Faculty of Food Technology and Biotechnology, University of Zagreb, Zagreb, Croatia
D. Coelho
Centro de Investigação Interdisciplinar em Sanidade Animal (CIISA), Faculdade de Medicina
Veterinária, Universidade de Lisboa, Avenida da Universidade Tecnica, Pólo Universitário
do Alto da Ajuda, Lisbon, Portugal
Marilyn C. Cornelis
Department of Preventive Medicine, Northwestern University Feinberg School of
Medicine, Chicago, IL, United States
Adriano Gomes da Cruz
Instituto Federal de Educação, Ci^encia e Tecnologia do Rio de Janeiro (IFRJ),
Departamento de Alimentos, Rio de Janeiro, Brazil
Sevtap Aydin Dilsiz
Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Hacettepe University,
Ankara, Turkey
Erick Almeida Esmerino
Universidade Federal Fluminense (UFF), Faculdade de Veterinária, Niterói, Brazil
ix
x Contributors
Jadranka Frece
Faculty of Food Technology and Biotechnology, University of Zagreb, Zagreb, Croatia
M^
onica Queiroz Freitas
Universidade Federal Fluminense (UFF), Faculdade de Veterinária, Niterói, Brazil
Advaita Ganguly
Comprehensive Tissue Centre, UAH Transplant Services, Alberta Health Services,
Edmonton, AB, Canada
Belen Gómez
Centro Tecnológico de la Carne de Galicia, Ourense, Spain
P.A. Lopes
Centro de Investigação Interdisciplinar em Sanidade Animal (CIISA), Faculdade de Medicina
Veterinária, Universidade de Lisboa, Avenida da Universidade Tecnica, Pólo Universitário
do Alto da Ajuda, Lisbon, Portugal
Jose M. Lorenzo
Centro Tecnológico de la Carne de Galicia, Ourense, Spain
M.S. Madeira
Centro de Investigação Interdisciplinar em Sanidade Animal (CIISA), Faculdade de Medicina
Veterinária, Universidade de Lisboa, Avenida da Universidade Tecnica, Pólo Universitário
do Alto da Ajuda, Lisbon, Portugal
Kaustav Majumder
Department of Food Science and Technology, University of Nebraska-Lincoln, Lincoln,
NE, United States
Ksenija Markov
Faculty of Food Technology and Biotechnology, University of Zagreb, Zagreb, Croatia
Paulo E.S. Munekata
Centro Tecnológico de la Carne de Galicia, Ourense, Spain; Department of Food
Engineering, College of Animal Science and Food Engineering, University of São Paulo,
São Paulo, Brazil
M. Ohata
College of Bioresource Sciences, Nihon University, Tokyo, Japan
J.M. Pestana
Centro de Investigação Interdisciplinar em Sanidade Animal (CIISA), Faculdade de Medicina
Veterinária, Universidade de Lisboa, Avenida da Universidade Tecnica, Pólo Universitário
do Alto da Ajuda, Lisbon, Portugal
Tatiana Colombo Pimentel
Instituto Federal do Paraná (IFPR), Campus Paranavaı́, Paranavaı́, Brazil
Jelka Pleadin
Croatian Veterinary Institute, Laboratory for Analytical Chemistry, Zagreb, Croatia
J.A.M. Prates
Centro de Investigação Interdisciplinar em Sanidade Animal (CIISA), Faculdade de Medicina
Veterinária, Universidade de Lisboa, Avenida da Universidade Tecnica, Pólo Universitário
do Alto da Ajuda, Lisbon, Portugal
Contributors xi
xiii
xiv Preface
the bioactive peptides would help in the design and characterization of more
potent peptides. Chapter 5 focuses on the relationship between diabetes
mellitus and preventive roles of various phytochemicals. Some of them such
as flavonoids, lignans, and prophenylphenols can play a preventive role on
diabetes via their antioxidant properties. Chapter 6 deals with a volatile
food component DMHF (2,5-dimethyl-4-hydroxy-3(2H)-furanone), with
attractive sensory properties. This substance is an aroma compound, gener-
ated in various foods by the Maillard reaction during cooking and
processing, that exhibits a strawberry-like flavor when diluted and a
caramel-like aroma when concentrated. It brings physiological functions
and bioactivity through inhalation. Chapter 7 addresses the potential of
insects and products derived from aquaculture as sustainable alternative
protein sources. It also discusses major challenges like the need to adapt
technologies and methods for the production and well-characterization of
the new ingredients, the evaluation of such new proteins in the diet and
its safety of use, including potential allergies, and the acceptance by
consumers. Finally, Chapter 8 brings the latest developments in mycotoxins
in foods. It describes the harmful effects of mycotoxins observed in humans
and animals like carcinogenicity, teratogenicity, immune toxicity,
neurotoxicity, hepatotoxicity, nephrotoxicity, reproductive and develop-
mental toxicity, indigestion, and so forth. The chapter includes the descrip-
tion of preventative measures capable of reducing the contamination to the
minimum as well as methods for mycotoxin reduction or elimination.
In summary, this volume presents the combined efforts of 38 profes-
sionals developing their research in 8 countries (Canada, USA, Brazil,
China, Turkey, Japan, Croatia, Portugal, and Spain) with a variety of
backgrounds and expertise. The Editor wishes to thank the production staff
and all the contributors for sharing their experience and for making this book
possible.
FIDEL TOLDRÁ
Editor
CHAPTER ONE
Contents
1. Introduction 2
2. Determinants of beverage consumption 3
3. Genetic determinants of beverage consumption 4
3.1 Early approaches: Linkage and candidate gene analysis 5
3.2 Recent approaches: Genome-wide analysis 7
4. Implications of genetic knowledge on beverage consumption 28
4.1 Research tools 28
4.2 Public health 34
5. Conclusions 35
Acknowledgment 36
References 36
Further reading 52
Abstract
Beverages make important contributions to nutritional intake and their role in health
has received much attention. This review focuses on the genetic determinants of com-
mon beverage consumption and how research in this field is contributing insight to
what and how much we consume and why this genetic knowledge matters from a
research and public health perspective. The earliest efforts in gene-beverage behavior
mapping involved genetic linkage and candidate gene analysis but these approaches
have been largely replaced by genome-wide association studies (GWAS). GWAS have
identified biologically plausible loci underlying alcohol and coffee drinking behavior.
No GWAS has identified variants specifically associated with consumption of tea, juice,
soda, wine, beer, milk or any other common beverage. Thus far, GWAS highlight an
important behavior-reward component (as opposed to taste) to beverage consumption
which may serve as a potential barrier to dietary interventions. Loci identified have been
used in Mendelian randomization and gene beverage interaction analysis of disease
but results have been mixed. This research is necessary as it informs the clinical rele-
vance of SNP-beverage associations and thus genotype-based personalized nutrition,
which is gaining interest in the commercial and public health sectors.
1. Introduction
Water is an essential nutrient for life ( Jequier & Constant, 2009). Bev-
erages contribute approximately 80% to total water intake with the remain-
der provided by solid foods (EFSA, 2010; Electrolytes & Water, 2005). After
water, coffee, tea, beer, milk, 100% juice, sugar sweetened beverages (SSB)
and wine are among the most widely consumed beverages in the world
(Euromonitor, 2018; Neves, Trombin, Lopes, Kalaki, & Milan, 2012;
Singh et al., 2015). Unlike plain water, beverages are also important sources
of energy, other vitamins and minerals as well as 1000s of non-nutrients,
many of which are bioactive. Coffee and tea, for example, are naturally
energy-free but important sources of caffeine and polyphenols. Beer and
wine both contain alcohol but also present with unique constituents includ-
ing hops and resveratrol, respectively. Juice and SSB are both energy dense
but the former is also a natural source of vitamins.
With their wide consumption and contributions to nutrient intake there
is great interest in the role beverages play in health. Epidemiological studies
support a beneficial role of moderate coffee intake in reducing risk of several
chronic diseases but heavy intake is likely harmful on pregnancy outcomes
(Poole et al., 2017). Tea might also reduce risk of type 2 diabetes (T2D),
metabolic syndrome (MetS) (Marventano et al., 2016; Yang, Mao, Xu,
Ma, & Zeng, 2014), osteoporosis (Sun et al., 2017) and cardiovascular dis-
eases (CVD) (Pang et al., 2016). Wine drinking may have a dose-dependent
association with health: low doses might protect against breast cancer and
CVD while high doses offer no benefit or increased risk (Chen et al.,
2016; de Gaetano, Di Castelnuovo, Rotondo, Iacoviello, & Donati,
2002). Health benefits or risks specific to beer and milk are unclear
(Gijsbers et al., 2016; Guo et al., 2017; Kaplan, Palmer, & Denke, 2000;
Larsson, Crippa, Orsini, Wolk, & Michaelsson, 2015; Lee, Fu, Chung,
Jang, & Lee, 2018; Li et al., 2011; Liu et al., 2015; Mullie, Pizot, &
Autier, 2016; Soedamah-Muthu et al., 2011). There are currently no
health benefits to SSB consumption but rather convincing data supporting
its role in obesity which is, in turn, a risk factor for several diseases
Genetic determinants of beverage consumption 3
(Malik et al., 2010; Malik, Schulze, & Hu, 2006). A caveat to our knowl-
edge pertaining to beverage consumption and human health is that much
of it is derived from epidemiological studies which have limitations
(Rothman, Greenland, & Lash, 2008; Taubes, 1995; Willett, 1998).
This review focuses on the genetic determinants of common beverage
consumption and how research in this field is contributing insight to what
and how much we consume and why this genetic knowledge matters from a
research and public health perspective.
Dagan-Wiener, & Niv, 2017). Coffee and beer are prime examples whereby
the innate eversion to bitter taste does not hold. Indeed, variants in
TAS2R43 linked to increased perception of caffeine, a bitter compound,
associate with increased coffee consumption and liking according to
candidate-SNP analysis (Ong et al., 2018; Pirastu et al., 2014). Although
coffee bitterness is easily offset by additives, some individuals may also learn
to associate this sensory cue with social context or postingestive signals
elicited by biologically active constituents of coffee. Variation in the TAS1R
sweet and umami receptor family has also been linked to alcohol consump-
tion behavior (Choi et al., 2017), wine drinking (Choi et al., 2017) and
vodka liking (Pirastu et al., 2012).
Besides taste-related genes, the candidate approach for alcohol-related
traits has additionally focused on alcohol metabolism genes including
ADH, CYP2E1 and ALDH (Fig. 1), as well as gene members of several neu-
rotransmitter systems: GIRK1, GABA-A, DRD2, SLC6A3, SLC6A4,
TPH1, COMT, CHRM2 and OPRM1 (Edenberg & Foroud, 2006;
Matsuo et al., 2006; Reilly, Noronha, Goldman, & Koob, 2017; Tawa,
Hall, & Lohoff, 2016). For coffee and tea drinking, candidate genes involved
in caffeine metabolism (CYP1A2) and caffeine’s target of action
(ADORA2A, DRD2) have been examined (Cornelis, 2012; Cornelis,
El-Sohemy, & Campos, 2007). Gene members of the brain reward system,
particularly DRD2, have been tested for associations with SSB (Baik, 2013;
Eny, Corey, & El-Sohemy, 2009; Ramos-Lopez, Panduro, Rivera-
Iñiguez, & Roman, 2018).
3.2.1 Alcohol
Successful GWAS of alcohol-related traits have been undertaken in
European, African American, Asian and Hispanic Latino populations. Most
of these targeted AD and included study samples with a high proportion of
individuals with comorbid psychiatric disorders and/or co-occurring drug
dependence. Several efforts report null findings (Heath et al., 2011;
Kapoor et al., 2014; Lydall et al., 2011; Mbarek et al., 2015; McGue
et al., 2013; Zuo et al., 2012), but inability to replicate some loci may be
a function of both case and control ascertainment (Frank et al., 2012;
Mailman et al., 2007). Most robust are associations with potentially func-
tional SNPs that alter alcohol metabolism (Fig. 1). For example, the ADH1B
rs1229984 T allele (48His) results in a 40- to 100-fold higher rate of alcohol
to acetaldehyde metabolism (i.e., ethanol oxidation) (Edenberg, 2000;
Hurley, Bosron, Stone, & Amzel, 1994). The ALDH2 rs671 A allele
(504Lys) reduces ALDH2 activity and thus decreases acetaldehyde to acetate
metabolism (i.e., acetaldehyde oxidation) (Bosron & Li, 1986; Enomoto,
Takase, Yasuhara, & Takada, 1991; Harada, Misawa, Agarwal, &
Goedde, 1980; Quillen et al., 2014). Acetaldehyde is a toxic substance
whose accumulation leads to a highly aversive reaction that includes facial
flushing, nausea, and tachycardia. The ADH1B His and ALDH2 Lys variants
influence alcohol drinking behavior by elevating blood acetaldehyde levels
upon alcohol drinking which ultimately reduces susceptibility to developing
alcohol drinking problems (Macgregor et al., 2009; Peng et al., 2010;
Takeuchi et al., 2011; Yokoyama et al., 2008).
Table 1 Genome-wide association studies of beverage consumption reporting significant loci.
Reference Phenotype Phenotype defined Study design N Race
Baik, Cho, Kim, Alcohol Self-reported alcohol consumption among ever Discovery 1721 Korean
Han, and Shin drinking drinkers
(2011) Questionnaire, alcohol g/day in the past month, Population-based males
derived
Alcohol Use Alcohol Use Disorder Identification Test Replication 1113
Disorder (AUDIT) score: <8 or 8 score
(NULL) Population-based males
Takeuchi et al. Alcohol Self-reported “ever” vs “non-drinkers” alcohol Discovery 733 ca Japanese
(2011) drinking consumption
Questionnaire, alcohol gou/wk also derived Population-based 729 co
Replication 2794 ca
Health center-based 1351 co
Schumann et al. Alcohol Self-reported alcohol consumption Discovery 26,316 EUR
(2011) drinking Self-reported alcohol consumption among ever
12 Population-based
drinkers (sex stratified)
Questionnaire, alcohol g/day per kg (no detail) Replication 21,185
7 Population-based
Yang et al. (2013) Alcohol Self-reported “drinkers” (12 drinks in past Discovery Chinese
drinking year) vs “non-drinkers” alcohol consumption
In-person interviews. 1 population-based 1420 ca
1 community-based 3590 co
For drinkers, alcohol g/d also derived (NULL) Replication 4896 ca
1 population-based 13,293 co
Continued
Table 1 Genome-wide association studies of beverage consumption reporting significant loci.—cont’d
Reference Phenotype Phenotype defined Study design N Race
Kapoor et al. Alcohol Maximum number of drinks consumed among Meta-analysis 4915 EUR
(2013) drinking drinkers COGA: AD probands recruited
In-person interview: “What is the largest through alcohol treatment programs;
number of drinks you have ever had in a 24-h relatives of the probands and
period”? (standard serving sizes per beverage) comparison families
Clarke et al. (2017) Alcohol Alcohol units/week (excluded former drinkers) One-sample 112,117 EUR
drinking
Sex-stratified GWAS UK Biobank (108,309
drinkers)
Self-reported computer questionnaire
Sanchez-Roige AD 10-item AUDIT questionnaire (scores 0–40) One-sample 20,328 EUR
et al. (2019) Included only subjects who answered yes to the 23andMe drinkers
question “Have you ever in your life used Direct to consumer genotyping service
alcohol”
Gelernter et al. Alcohol Flushing, maximum number of alcoholic Meta-analysis 1045 drinkers Thai
(2018) drinking beverages consumed in any lifetime 24-h
period, and DSM-IV AD criterion count. Two samples of methamphetamine
users, dependent subjects and exposed
Only alcohol-exposed subjects were included
but not dependent
In-person interview
Treutlein et al. AD AD: based on DSM-IV criteria Discovery 476 ca EUR
(2009)
Interview Male in-patients and population-based 1358 co
controls
Replication 1024 ca
Male in-patients and matched controls 996 co
Kendler et al. AD Abstainers excluded, alcohol factor scores One sample, Race-strata 2357 EUR
(2011) among drinkers based on alcohol-related
812 AA
symptoms
Survey-based recruitment
Online questionnaire: Composite
International Diagnostic Interview—Short
Form, modified to screen for lifetime
diagnoses
Wang et al. (2011) AD Discovery: DSM-IV diagnosis (interview) Discovery 1283 ca EUR
Replication: telephone diagnostic interview Meta-analysis: 1416 co
COGA and SAGE
Replication 1650 ca EUR
OZALC (family based) 1684 co
Frank et al. (2012) AD DSM-IV criteria Pooled sample analysis (males) extends 1333 ca EUR
Treutlein et al. (2009) with more
in-patients/controls 2168 co
Zuo et al. (2013) AD DSM-IV criteria for AD, controls: exposed to Discovery 1409 ca EUR
alcohol but not addicted
SAGE and COGA 1518 co
Replication 6438
OZ-ALC European-
Australian
family
subjects with
1645
probands
Park et al. (2013) AD DSM-IV diagnosis interview Discovery Korean
Drinking habit questionnaire (controls)
Cases: in-patients 117 ca
Controls: non-alcoholics (hospital 279 co
based)
Replication
Cases: in-patients 504 ca
Controls: “normal” 471 co
Continued
Table 1 Genome-wide association studies of beverage consumption reporting significant loci.—cont’d
Reference Phenotype Phenotype defined Study design N Race
Sulem et al. (2011) Coffee Cups/d among drinkers Discovery 6611 EUR
Self-reported, questionnaire or in-person 4 population-based,
interviews 1 genetic isolate
Replication 4050 EUR
2 population-based
Amin et al. (2012) Coffee 5 categories of intake Discovery 18,176 EUR
Self-reported, semi-quantitative FFQ 8 population-based
Replication 7929 EUR
1 population-based
Cornelis et al. Coffee Cups/d among drinkers Discovery 91,462 EUR
(2015)
High vs low/non drinkers 28 population-based
Self-reported, questionnaire or in-person Replication
interviews
13 population based 30,062 EUR
7 population based 7964 AA
Pirastu et al. (2016) Coffee Cups/d Discovery 1213 EUR
Self-reported, questionnaire or in-person
interviews 2 genetic isolate populations
Replication
1 genetic isolate 1731 EUR
Nakagawa-Senda Coffee Cups/d Discovery 6312 Japanese
et al. (2018) Self-reported, questionnaire
Replication 4949
Both samples drawn from the same
multi-site population-based study
Pirastu et al. (2016) Food/beverage Liking/disliking scale (coffee, whole milk and Discovery 2240 EUR
liking beer amongst 20 items tested)
Questionnaire administered by an operator 3 genetic isolate populations
Replication 1596 EUR
1 genetic isolate
1 community sample
Pirastu et al. (2015) Wine liking Liking/disliking scale Discovery 2240 EUR
White and red wine tested
Questionnaire administered by an operator 3 genetic isolate populations
Replication 1596 EUR
1 genetic isolate
1 community sample
Zhong et al. (2019) Total bitter Coffee (any type), tea (any type), grapefruit Discovery 85,852 EUR
beverages intake juice, beer/cider, red wine, spirit/liquor
Servings/day, self-reported, questionnaire UK Biobank
Replication 39,924 EUR
3 US cohorts
Bitter alcoholic Beer/cider, red wine, spirit/liquor Discovery 336,448 EUR
beverage intake Servings/day, self-reported, questionnaire
UK Biobank
Replication 39,924 EUR
3 US cohorts
Continued
Table 1 Genome-wide association studies of beverage consumption reporting significant loci.—cont’d
Reference Phenotype Phenotype defined Study design N Race
Bitter non- Coffee (any type), tea (any type), grapefruit juice Discovery 85,852 EUR
alcoholic
beverage intake UK Biobank
Servings/day, self-reported, questionnaire Replication 39,924 EUR
3 US cohorts
Coffee intake Any type (i.e., regular/decaf, instant/ground) Discovery 335,909 EUR
UK Biobank
Servings/day, self-reported, questionnaire Replication 39,924 EUR
3 US cohorts
Tea intake Any type (i.e., regular/decaf, herbal/non- Discovery 85,852 EUR
herbal)
UK Biobank
Servings/day, self-reported, questionnaire Replication 39,924 EUR
3 US cohorts
Grapefruit juice Servings/day, self-reported, questionnaire Discovery 85,852 EUR
intake
UK Biobank
Replication 39,924 EUR
3 US cohorts
Zhong et al. (2019) Total sweet Sugary carbonated beverages, flavored juice Discovery 85,852 EUR
beverage intake beverages with sugar, any low-calorie or diet
non-alcoholic beverages, pure fruit juice UK Biobank
(excluding grapefruit juice), flavored milk, hot
chocolate
Servings/day, self-reported, questionnaire Replication 39,924 EUR
3 US cohorts
Sugar Sugary carbonated beverages, flavored juice Discovery 85,852 EUR
sweetened beverages with sugar
beverages UK Biobank
(SSBs) Servings/day, self-reported, questionnaire Replication 39,924 EUR
3 US cohorts
Artificially Any low-calorie or diet non-alcoholic Discovery 85,852 EUR
sweetened beverages
beverages UK Biobank
(ASBs) Servings/day, self-reported, questionnaire Replication 39,924 EUR
3 US cohorts
Pure non- Excluding grapefruit juice Discovery 85,852 EUR
grapefruit juices
UK Biobank
Servings/day, self-reported, questionnaire Replication 39,924 EUR
3 US cohorts
Table 2 Genome-wide significant loci for beverage consumption behavior.
EAF
Closest
Locus gene(s) SNP, EA AFR AMR ASN EU Race origin Trait Effect Reference Assoc. with other traits
1p35.2 SERINC2 rs4478858, G 0.55 0.5 0.79 0.45 EU AD + Zuo et al. (2013), Zuo
intronic et al. (2015)
1q21.3 ANXA9 rs12405726, A 0.09 0.5 0.43 0.36 EU Bitter non-alcoholic + Zhong et al. (2019) Serum urate
intronic beverage intake
1q25.1 KIAA0040, rs6701037, C 0.33 0.32 0.09 0.46 EU AD + Wang et al. (2011)
TNN intergenic
1q25.1 SERPINC1 rs1799876, G 0.86 0.35 0.6 0.33 EU Alcohol intake Xu et al. (2015)
intronic
1q25.2 SEC16B rs574367, T 0.09 0.15 0.19 0.21 EU Coffee intake + Zhong et al. (2019) BMI, obesity,
intergenic menarche
2p25.3 TMEM18 rs10865548, G 0.93 0.85 0.9 0.83 EU Coffee intake + Zhong et al. (2019) BMI, obesity, weight,
intergenic menarche
2p23.3 GCKR rs1260326, T 0.12 0.41 0.56 0.41 EU/AFR Coffee intake Cornelis et al. (2015), Waist circumference,
missense Zhong et al. (2019) lipid traits, serum
glucose, chronic
EU/AFR/ Alcohol intake, bitter Clarke et al. (2017), kidney disease,
ASN/HL alcoholic beverage Jorgenson et al. (2017), C-reactive protein,
intake Zhong et al. (2019) gamma-glutamyl
Borderline Schumann transferase, serum
et al. (2011) albumin, serum urate,
EU Total bitter beverage Zhong et al. (2019) leptin
intake
2p16.1 MTIF2— rs1437396, T 0.11 0.17 0.5 0.2 EU/AFR AD Gelernter et al. (2013)
CCDC88A intergenic
2p12 CTNNA2 rs140089781, A 0.0 0.0 0.02 <0.01 EU Alcohol intake (men) Clarke et al. (2017)
intronic
2q35 PECR rs7590720, G 0.25 0.26 0.31 0.29 EU AD + Treutlein et al. (2009)
intronic
3p12.1 CADM2 rs13078384, A 0.02 0.20 0.02 0.33 EU Alcohol intake + Clarke et al. (2017)
intronic
4p14 KLB, U6 rs7686419, A 0.45 0.38 0.46 0.47 EU/AFR/ Alcohol intake Jorgenson et al. (2017)
intergenic ASN/HL
4p14 KLB rs11940694, A 0.38 0.61 0.57 0.40 EU Alcohol intake, bitter Clarke et al. (2017),
intronic alcoholic beverage Schumann et al. (2016),
intake Zhong et al. (2019)
4q22.1 ABCG2 rs1481012, A 0.98 0.85 0.71 0.89 EU (AA) Coffee intake + Cornelis et al. (2015) LDL, response to statin,
intronic serum urate, gout
Total bitter beverage + Zhong et al. (2019)
intake
4q23 ADH4- rs1229984, T 0.0 0.08 0.73 <0.01 EU/AFR/ AD, AD symptoms, Clarke et al. (2017), Frank Esophageal cancer,
ADH7, missense ASN/HL alcohol intake, bitter et al. (2012), Gelernter upper aerodigestive
ADH1A-C alcoholic beverage et al. (2013), Jorgenson tract cancers, oral
intake et al. (2017), Kapoor et al. cavity cancer,
(2013), Park et al. (2013), oropharynx cancer,
Treutlein et al. (2017), Xu pulse pressure
et al. (2015)
5q35.2 CTB- rs1363605, G 0.6 0.73 0.43 0.81 EU/AA AD symptom count + Chen et al. (2017)
33O18.3 intergenic
6p21.33 NRM rs2269705, A 0.71 0.88 0.95 0.94 EU/AA AD symptom count Chen et al. (2017)
intronic
6p21.32 HLA-DOA rs9276975, T 0.06 0.15 0.17 0.15 EU White wine liking + Pirastu et al. (2015)
30 UTR
Continued
Table 2 Genome-wide significant loci for beverage consumption behavior.—cont’d
EAF
Closest
Locus gene(s) SNP, EA AFR AMR ASN EU Race origin Trait Effect Reference Assoc. with other traits
6q21 PDSS2 rs2216084, T 0.96 0.64 0.99 0.67 EU Coffee intake + Pirastu, Kooyman,
intronic Robino, et al. (2016)
7p21.1 AHR rs4410790, T 0.53 0.58 0.63 0.38 EU/AA Coffee intake Cornelis et al. (2015), Albuminuria
intergenic Sulem et al. (2011),
Zhong et al. (2019)
Borderline Nakagawa-
Senda et al. (2018)
EU Caffeine intake Cornelis et al. (2011)
EU Bitter non-alcoholic Zhong et al. (2019)
beverage intake
EU Total bitter beverage Zhong et al. (2019)
intake
7q11.22 AUTS2 rs6943555, A 0.59 0.28 0.33 0.22 EU Alcohol intake + Schumann et al. (2011)
intronic
7q11.23 MLXIPL rs7800944, T 0.61 0.82 0.89 0.72 EU Coffee intake Cornelis et al. (2015), Lipid traits
intronic Zhong et al. (2019)
Bitter non-alcoholic Zhong et al. (2019)
beverage intake
7q11.23 POR rs17685, A 0.13 0.22 0.35 0.30 EU/AA Coffee intake + Cornelis et al. (2015),
30 UTR Zhong et al. (2019)
EU Bitter non-alcoholic + Zhong et al. (2019)
beverage intake
EU Total bitter beverage + Zhong et al. (2019)
intake
7q31.1 NRCAM rs382140, A 0.45 0.21 0.19 0.18 EU Coffee intake + Amin et al. (2012)
intergenic
7q32.3 PODXL rs2909678, C 0.48 0.74 0.41 0.86 EU/AA AD symptom count Chen et al. (2017)
Intergenic
11p14.2 FIBIN rs145671205, C 0.04 0.07 0.06 0.07 EU Coffee liking Pirastu, Kooyman,
intergenic Traglia, et al. (2016)
11p11.2 AGBL2 rs7935528, A 0.14 0.34 0.35 0.42 EU Bitter alcoholic + Zhong et al. (2019)
beverage intake
11q12.1 OR8U8 rs597045, A 0.97 0.82 0.86 0.69 EU Coffee intake + Zhong et al. (2019)
intergenic
12q24.11- ALDH2 rs671, G 1 1 0.88 1 ASN AD, AD symptoms, + Baik et al. (2011), Frank Lipid traits, gamma-
13 missense alcohol intake, flushing et al. (2012), Gelernter glutamyl transferase,
response et al. (2018), Jorgenson serum urate, serum
et al. (2017), Quillen et al. alpha-1-antitrypsin,
(2014), Takeuchi et al. esophageal cancer,
(2011) hemoglobin, CHD,
brain aneurysm,
ASN Coffee intake Nakagawa-Senda et al. metabolic syndrome,
(2018) BMI
14q12 AKAP6 rs1956218, G 0.68 0.66 0.44 0.53 EU Coffee intake + Zhong et al. (2019)
intronic
14q23.1 ARID4A rs8012947, A 0.27 0.3 0.62 0.28 EU Alcohol intake + Clarke et al. (2017)
intronic
15q24.1 CYP1A1- rs2472297, T 0.02 0.09 0.0 0.24 EU/AA Coffee intake + Amin et al. (2012), Albuminuria, urine
CYP1A2 intergenic Cornelis et al. (2015), albumin,
Sulem et al. (2011),
Zhong et al. (2019)
Continued
Table 2 Genome-wide significant loci for beverage consumption behavior.—cont’d
EAF
Closest
Locus gene(s) SNP, EA AFR AMR ASN EU Race origin Trait Effect Reference Assoc. with other traits
ALDH2 and ADH1B are the only susceptibility genes that were studied
as candidate SNPs before they were highlighted via agnostic GWAS
(Li, Zhao, & Gelernter, 2011; Takeuchi et al., 2011). Variants in SERINC2,
KIAA0040, MTIF2-CCDC88A, and PECR have also been associated with
AD in GWAS. Variation in SERINC2, encoding a transmembrane trans-
porter of L-serine, may potentially alter glycine and glutamate neurotrans-
mission contributing to hyperexcitability and negative affect during
alcohol abstinence (Furuya & Watanabe, 2003; Hirabayashi & Furuya,
2008; Reilly et al., 2017; Smith, 2000; Tabatabaie, Klomp, Berger, & De
Koning, 2010). KIAA0040 has no obvious role in alcohol consumption
behavior but is closely situated to (i) ASTN1, which has been associated with
AD and substance dependence (Gratacòs et al., 2009; Hill et al., 2012),
(ii) TNN encoding tenascin-N; involved in neurite outgrowth and cell
migration in hippocampal explants and (iii) TNR, encoding tenascin-R;
an extracellular matrix protein expressed primarily in the central nervous
system and has been related to multiple brain diseases (Reilly et al.,
2017). CCDC88A is the most promising candidate at 2p16, a region also
implicated in a previous linkage study of AD (Dick et al., 2010). CCDC88A
is differentially expressed in AD (Gelernter et al., 2013) and interacts with
DISC1, a gene associated with both schizophrenia (Kim et al., 2012) and
opioid dependence (Xie et al., 2014). PECR encodes a protein that partic-
ipates in chain elongation of fatty acids and is an integral component of per-
oxisomes which play a key role in protection against oxidative stress
particularly in glial cells (Di Cesare Mannelli, Zanardelli, Micheli, &
Ghelardini, 2014; Varga, Czimmerer, & Nagy, 2011). Variants at 5q35,
6p21, and 7q32 have also been associated with AD symptoms but not clin-
ically diagnosed AD.
Variants linked to AD may not necessarily equate with habitual alcohol
consumption in general population. The latter has been addressed by inde-
pendent GWAS often involving several 1000s of individuals. Indeed, aside
from ALDH2 and ADH1B, none of the loci associated with habitual alcohol
consumption associate with AD, although this may be a function of the study
design rather than real biological differences between these traits. Variants in
CADM2 associated with alcohol consumption have also been associated
with cognitive ability, reproductive success, risk-taking propensity and
cannabis use (Davies et al., 2016; Day et al., 2016; Ibrahim-Verbaas et al.,
2016; Stringer et al., 2017). Following-up on their well replicated KLB-
alcohol association (Clarke et al., 2017; Jorgenson et al., 2017; Schumann
et al., 2016), Schumann et al. (2016) identified a liver-brain axis linking
26 Marilyn C. Cornelis
the liver hormone FGF21 with central regulation of alcohol intake involving
β-Klotho receptor (encoded by KLB) in the brain. FGF21 is induced in liver
and released into the blood in response to various metabolic stresses, includ-
ing high-carbohydrate diets and alcohol (Dushay et al., 2015; Sanchez,
Palou, & Pico, 2009; Zhao et al., 2015). FGF21 was also shown to suppress
sweet and alcohol preference in mice (Talukdar et al., 2016; von Holstein-
Rathlou et al., 2016). The function of another GWAS AD candidate,
AUTS2, is unknown, but significant differences in expression of AUTS2
in whole-brain extracts of mice selected for differences in voluntary alcohol
consumption as well as reduced alcohol sensitivity in Drosophila with a
downregulated AUTS2 homolog (Schumann et al., 2011) support a poten-
tial role of AUTS2 in alcohol drinking behavior. The role of other loci asso-
ciated with alcohol-related traits is unclear and/or require stronger support
in independent studies.
3.2.2 Coffee
GWAS have identified multiple genetic variants associated with self-
reported habitual coffee consumption (Amin et al., 2012; Coffee and
Caffeine Genetics Consortium et al., 2015; Cornelis et al., 2011; Sulem
et al., 2011; Zhong et al., 2019), many of which point to caffeine-related
pathways. All of these GWAS have been population-based but predomi-
nately of individuals of European Ancestry. The earlier GWAS confirmed
loci near AHR, CYP1A2, POR, and ABCG2 which generally present with
the largest effect sizes and likely impact drinking behavior indirectly by alter-
ing the metabolism of caffeine and thus the physiological levels of this com-
pound available for its psychostimulant effects. CYP1A2, for example, is
responsible for over 95% of caffeine metabolism (Thorn, Aklillu,
Klein, & Altman, 2012). Indeed, a subsequent GWAS of circulating caffeine
metabolite levels further informed the roles of these loci in caffeine metab-
olism (Cornelis et al., 2016). Genetic variants leading to increased coffee/
caffeine consumption associate with lower circulating caffeine levels and
higher paraxanthine-to-caffeine ratio suggesting a fast caffeine metabolism
phenotype (Cornelis et al., 2016). Loci near ADORA2A, BDNF and
SLC6A4 likely act directly on coffee drinking behavior by modulating the
acute psychostimulant and rewarding properties of caffeine. GWAS and
smaller follow-up studies have linked several of these loci to consumption
of regular coffee, decaffeinated coffee, tea, total caffeine and water and fur-
ther extended the findings to African American and Japanese populations
(Coffee and Caffeine Genetics Consortium et al., 2015; McMahon,
Genetic determinants of beverage consumption 27
Many loci associated with beverage drinking traits are more strongly associated
with other traits based on GWAS (Table 2) (MacArthur et al., 2017). Whether
this results from pleiotropy or a true causal relationship between a beverage
and these other traits is unclear.
The term “interaction” has various meanings but the focus of the current
discussion is on G D interaction, here defined as a joint effect of one or
more genes with one or more dietary factors that cannot be readily explained
by their separate marginal effects. By convention, a multiplicative model is
taken as the null hypothesis: the relative risk of disease in individuals with
both the genetic and dietary risk factors is the product of the relative risks
of each separately. Therefore, any joint effect that differs from this prediction
is considered to be a form of interaction (Rothman & Greenland, 1998;
Thomas, 2010). The nature of the interaction can also vary. The main effect
of both genotype and beverage intake may be greater in one stratum (i.e.,
intake level or genotype) than in the other strata, or it may have the opposite
effect in one stratum compared with the others (Rothman & Greenland,
1998). Because some statistical techniques used in MR and G D interac-
tions are common it is sometimes difficult to distinguish between the
approaches. While the primary goal of MR is to establish causality a unique
feature of G D interactions is they can potentially provide mechanistic
insight into diet’s role in disease. Following are examples of how these
methods have been applied to beverage and health research.
4.1.1 Alcohol
Most of the genetic epidemiological studies of alcohol have focused on
the ALDH2 Glu504Lys (rs671) and ADH1B1 Arg48His (rs1229984) poly-
morphisms, wherein the ALDH2 Lys (A allele) and ADH1B1 His (T allele)
variants associate with lower alcohol consumption due to adverse reaction to
alcohol as a result of higher circulating acetaldehyde. These variants are most
common in Asians (Table 2) and thus most genetic studies have included
Asian populations. Several studies report that individuals with ALDH2
Lys/Lys genotype have no or a lower risk of esophageal cancer while those
with Lys/Glu are at increased risk compared to Glu/Glu. This provides
strong evidence that alcohol intake increases the risk of esophageal cancer
and individuals whose genotype results in markedly lower intake (i.e.,
Lys/Lys) due to an adverse reaction to alcohol are thus protected (Fang
et al., 2011; Lewis & Smith, 2005; Yang et al., 2010; Zhang, Mai, &
Huang, 2010a; Zhao et al., 2015). Heterozygotes have a limited ability to
Another random document with
no related content on Scribd:
“You go down to your tea and leave her ladyship’s looks alone. I
don’t know what you’re doing hanging about this landing at such an
hour of the day.”
Payne was an old servant in the Wynyard family, and he was aware
it had been generally said that “Master Owen had the looks and Miss
Leila the brains.” Master Owen was always a wild, harum-scarum
young fellow, and it wasn’t at all unlikely that he had got into one of
his scrapes. With this conviction implanted in his mind, Payne
deliberately descended the stairs, issued an edict to one of the
footmen, and retired into his lair and the evening paper.
CHAPTER II
BROTHER AND SISTER